ADVENZYMES: Q2 FY27 growth accelerated, led by Industrial Bio-Processing and Animal Nutrition

Less than 1 min read

Q2 FY27 revenue rose 16% YoY and EBITDA 20%, with Industrial Bio-Processing and Animal Nutrition driving strong gains. H1 revenue grew 10%, while Human Nutrition was broadly flat.

Original document: [Advanced Enzyme Technologies Ltd [ADVENZYMES] Slides Release — Nov. 3 2026](https://www.tradingview.com/accounts/signin?next=https%3A%2F%2Fnews-mediator.tradingview.com%2Fdoc-screener%2Fv1%2Ffiles%2Furn%3Aslides%3Aquartr.com%3A4257179-b1d49cc2a7b30870b41335d09b0feaad)

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.